Die Equinen Herpesviren – Ein Update

Infektionen mit Equinen Herpesviren (EHV) sind weitverbreitet und können schwerwiegende klinische Probleme erzeugen. Vor allem EHV-1 wird durch Spätaborte und Equine Herpes Myeloenzephalopathie (EHM) als bedeutendes Pathogen des Pferdes eingeordnet. In den letzten Jahren wurden große Fortschritte im Verständnis der EHV-1-Epidemiologie und Pathogenese gemacht, viele Wissenslücken müssen jedoch noch geschlossen werden.

• Literatur

• 1 Allen G, Kydd JH, Slater JD, Smith KC. Advances in understanding of the pathogenesis, epidemiology and immunological control of equine herpesvirus abortion. Equine infectious diseases VII Prodeeding of the Eighth International Conference, Dubai, 23 – 26 March. 1998: 129-146
• 2 Barrandeguy M, Thiry E. Equine coital exanthema and its potential economic implications for the equine industry. Vet J 2012; 191: 35-40
• 3 Fortier G, van Erck E, Pronost S, Lekeux P, Thiry E. Equine gammaherpesviruses: pathogenesis, epidemiology and diagnosis. Vet J 2010; 186: 148-156
• 4 Gardiner DW, Lunn DP, Goehring LS, Chiang YW, Cook C, Osterrieder N, McCue P, Del Piero F, Hussey SB, Hussey GS. Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: viral loads in fetal and placental tissues and foals. Vaccine 2012; 30: 6564-6572
• 5 Greenwood AD, Tsangaras K, Ho SY, Szentiks CA, Nikolin VM, Ma G, Damiani A, East ML, Lawrenz A, Hofer H, Osterrieder N. A potentially fatal mix of herpes in zoos. Curr Biol 2012; 22: 1727-1731
• 6 Heldens JG, Hannant D, Cullinane AA, Prendergast MJ, Mumford JA, Nelly M, Kydd JH, Weststrate MW, van den Hoven R. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1, 4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 2001; 19: 4307-4317
• 7 Lunn DP, Davis-Poynter N, Flaminio MJ, Horohov DW, Osterrieder K, Pusterla N, Townsend HG. Equine herpesvirus-1 consensus statement. Journal of veterinary internal medicine/American College of Veterinary Internal Medicine 2009; 23: 450-461
• 8 Nordengrahn A, Merza M, Ros C, Lindholmc A, Palfl V, Hannant D, Belak S. Prevalence of equine herpesvirus types 2 and 5 in horse populations by using type-specific PCR assays. Veterinary research 2002; 33: 251-259
• 9 Nugent J, Birch-Machin I, Smith KC, Mumford JA, Swann Z, Newton JR, Bowden RJ, Allen GP, Davis-Poynter N. 2006, Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. Journal of virology 2006; 80: 4047-4060
• 10 Perkins GA, Goodman LB, Tsujimura K, Van de Walle GR, Kim SG, Dubovi EJ, Osterrieder N. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984–2007). Veterinary microbiology 2009; 139: 375-378
• 11 Pusterla N, Mapes S, Wademan C, White A, Estell K, Swain E. Investigation of the role of mules as silent shedders of EHV-1 during an outbreak of EHV-1 myeloencephalopathy in California. The Veterinary record 2012; 170: 465
• 12 Pusterla N, Mapes S, Wilson WD. 2010, Prevalence of equine herpesvirus type 1 in trigeminal ganglia and submandibular lymph nodes of equids examined postmortem. The Veterinary record 2010; 167: 376-378
• 13 Smith KC, Borchers K. 2001, A study of the pathogenesis of equid herpesvirus-1 (EHV-1) abortion by DNA in-situ hybridization. Journal of comparative pathology 2001; 125: 304-310
• 14 Stierstorfer B, Eichhorn W, Schmahl W, Brandmuller C, Kaaden OR, Neubauer A. 2002, Equine herpesvirus type 1 (EHV-1) myeloencephalopathy: a case report. Journal of veterinary medicine B 2002; 49: 37-41
• 15 van Maanen C. Equine herpesvirus 1 and 4 infections: An update. The Veterinary quarterly 2002; 24: 57-78